Averix Bio is a science-based company, dedicated to understanding the medical and therapeutic value of cannabinoids extracted from industrial hemp. By establishing ourselves on the front lines of research and development, Averix Bio has positioned itself to become a global leader in the hemp-based health and science market.
CBDepot is a pioneer in the production of high-quality cannabinoid ingredients. The company, with roots dating to 2014, has been a leader in helping to establish legal and quality standards for cannabinoid ingredients and the formulation of cannabidiol derivatives that have a fastgrowing presence in sectors including food, cosmetics, pharmaceuticals and other health products.
Eurofins companies scientists are leading global experts in hemp and CBD analysis and verification. In fact, we developed the first globally recognized (AOAC) method for testing the potency of hemp. Our scientific teams collaborate with you to develop innovative, tailored testing solutions so you can be sure you’re delivering the safest, highest quality CBD products to market.
Kare is a chemical technology company specializing in the research, development and commercialization of catalysts, precursors and industrial processes to create pure cannabinoids. Our high throughput catalyst technologies are used for producing laboratory derived high quality cannabinoids such as CBD, THC, CBN that are chemically identical to their plantderived counterparts. The advantage of synthetic cannabinoids relative to products extracted from plants is the stability of supply and control over quality and scalability, alongside the ability to produce rare cannabinoids.
KinetoChem LLC is a US-based company manufacturing high purity synthetic cannabinoids for all research stages offering APIs for pre-clinical, clinical, and consumer goods. Our facility and manufacturing processes meet all state and federal regulatory requirements including DEA Schedule I licensing for Analysis, Bulk Manufacturing, and Export. KinetoChem has over 10 years’ experience manufacturing clinical and commercial quantities of synthetic THC,CBD and other minor cannabinoids. With our experience, we can help customers create the next cannabinoid finished drug product.
Purisys has more than a decade of experience developing and manufacturing cannabinoids – starting with a commercial Drug Master File for Δ9-THC (dronabinol) API since 2007. Our personnel have a 40-plus year track record managing controlled substance APIs for pharmaceutical production in accordance with international rules and global regulations. We offer technical support in every phase of the drug development process, from preclinical studies through commercialization of a wide variety of dosage forms and formulations.
Cannabinoid science has opened the door to the development of FDA-approved plant-derived cannabinoid medications that are used to treat a number of neurological diseases. Over more than two decades, GW Pharmaceuticals/Greenwich Biosciences, now a part of Jazz Pharmaceuticals, established a world-leading cannabinoid science platform to develop a deep, innovative pipeline of early and late-stage cannabinoid product candidates and highly specialized growing and manufacturing expertise.
Next Frontier Brands is a leading consumer packaged goods company focused on beverages products. The company has an innovative and influential portfolio of brands that connects with consumers, evolves with their preferences, and delivers consistently superior experiences. Headquartered in Boulder, Colorado and offices in London, Portland and Auckland, Next Frontier Brands is building the global platform to serve the growing demand for innovative beverage brands.